Teva Pharmaceutical Industries (TEVA) Could Be 11% Undervalued As FDA Accepts Ecopipam Filing

Teva Pharmaceutical Industries (NYSE:TEVA) is back in focus after the U.S. Food and Drug Administration accepted its New Drug ...

Are Oklo and NuScale Power Still a Buy After Data Center Backlash?

"The race to scale AI has triggered one of the largest infrastructure build-outs in modern history," observes a recent report from global consultancy firm McKinsey & Co. "By our estimates, global ...

Wall Street Isn't Giving Up on CVS Health -- and Its Valuation Looks Stronger Than Investors Think

CVS is predicting revenue of at least $414 billion in 2026, up from earlier estimates of at least $405 billion. Yearly EPS ...

Peter Thiel's Fund Reported Zero Stocks for 2 Straight Quarters. Its $419 Million Comeback Put 72% Into Energy and Power.

One caveat belongs up front. A 13F filing covers only a manager's long positions in certain U.S.-listed securities. Short ...